Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1964 7
1965 4
1966 1
1967 3
1968 10
1969 11
1970 16
1971 44
1972 64
1973 54
1974 58
1975 59
1976 68
1977 73
1978 81
1979 97
1980 75
1981 84
1982 114
1983 125
1984 140
1985 238
1986 191
1987 230
1988 233
1989 300
1990 379
1991 357
1992 454
1993 618
1994 741
1995 957
1996 1187
1997 1384
1998 1509
1999 1870
2000 2244
2001 2563
2002 3146
2003 3564
2004 3919
2005 4531
2006 4808
2007 5388
2008 5908
2009 6258
2010 7211
2011 7739
2012 8523
2013 8901
2014 9319
2015 9774
2016 9875
2017 10220
2018 10178
2019 10149
2020 7101
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

136,710 results
Results by year
Filters applied: . Clear all
Page 1
Hematopoietic stem cell transplantation for acute myeloid leukemia.
Takami A. Takami A. Int J Hematol. 2018 May;107(5):513-518. doi: 10.1007/s12185-018-2412-8. Epub 2018 Jan 27. Int J Hematol. 2018. PMID: 29374826 Review.
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) yields a high rate of curability for acute myeloid leukemia (AML), it is also associated with transplant-related morbidity and mortality (TRM). ...It has also recently been …
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) yields a high rate of curability for acu …
Major Pulmonary Complications After Hematopoietic Stem Cell Transplant.
Diab M, ZazaDitYafawi J, Soubani AO. Diab M, et al. Exp Clin Transplant. 2016 Jun;14(3):259-70. doi: 10.6002/ect.2015.0275. Epub 2016 Apr 4. Exp Clin Transplant. 2016. PMID: 27040986 Free article. Review.
Pulmonary complications, although they have become less frequent, remain a significant cause of morbidity and mortality after hematopoietic stem cell transplant. ...This report highlights the advances in the diagnosis and management of the major pulmon …
Pulmonary complications, although they have become less frequent, remain a significant cause of morbidity and mortality after hematopoiet
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
Khosla J, Yeh AC, Spitzer TR, Dey BR. Khosla J, et al. Bone Marrow Transplant. 2018 Feb;53(2):129-137. doi: 10.1038/bmt.2017.207. Epub 2017 Oct 2. Bone Marrow Transplant. 2018. PMID: 28967899 Free article. Review.
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA) remains a difficult complication to address due to its high mortality rate, lack of standard diagnostic criteria and limited therapeutic options. ...
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA) remains a difficult compl
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. Passweg JR, et al. Bone Marrow Transplant. 2016 Jun;51(6):786-92. doi: 10.1038/bmt.2016.20. Epub 2016 Feb 22. Bone Marrow Transplant. 2016. PMID: 26901709 Free PMC article.
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. ...Changes in transplant activity inc …
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic ( …
Who is the best donor for haploidentical stem cell transplantation?
Kongtim P, Ciurea SO. Kongtim P, et al. Semin Hematol. 2019 Jul;56(3):194-200. doi: 10.1053/j.seminhematol.2018.08.003. Epub 2018 Aug 24. Semin Hematol. 2019. PMID: 31202430 Review.
Recent advances in haploidentical stem cell transplantation have enabled the use of human leukocyte antigen-half matched related donors for allogeneic stem cell transplantation and helped overcome one of the most important limitation in …
Recent advances in haploidentical stem cell transplantation have enabled the use of human leukocyte antigen-half matche …
Hematopoietic stem cell transplantation: clinical use and perspectives.
Barriga F, Ramírez P, Wietstruck A, Rojas N. Barriga F, et al. Biol Res. 2012;45(3):307-16. doi: 10.4067/S0716-97602012000300012. Biol Res. 2012. PMID: 23283440 Free article.
Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of malignant and non-malignant diseases in children and adults. ...The procedure has helped to obtain key information about the bone marrow environment, the biology
Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of malignant and non-mal
Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis.
Metheny L, de Lima M. Metheny L, et al. Expert Rev Hematol. 2019 Jan;12(1):47-60. doi: 10.1080/17474086.2019.1562331. Epub 2018 Dec 29. Expert Rev Hematol. 2019. PMID: 30582393 Review.
Allogeneic hematopoietic cell transplantation is frequently used to treat malignant and non-malignant conditions, and many patients lack a human leukocyte antigen (HLA) matched related or unrelated donor. ...For mismatched unrelated donors we recommend young …
Allogeneic hematopoietic cell transplantation is frequently used to treat malignant and non-malignant conditions, and m …
Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N, Pignataro F, Zaccara E, Maglione W, Minniti A. Del Papa N, et al. Front Immunol. 2018 Oct 16;9:2390. doi: 10.3389/fimmu.2018.02390. eCollection 2018. Front Immunol. 2018. PMID: 30386340 Free PMC article. Review.
In this scenario, it is not surprising that SSc was one of the first autoimmune diseases challenged with high-dose immunosuppressive treatment followed by autologous hematopoietic stem cell transplantation (AHSCT). ...As the studies have progressed, it …
In this scenario, it is not surprising that SSc was one of the first autoimmune diseases challenged with high-dose immunosuppressive treatme …
Hematopoietic Stem Cell Transplant in Facilities Without Intensive Care Units in Japan.
Kamio T, Sanui M, Horikita S, Fujii T, Kawagishi T, Lefor AK. Kamio T, et al. Exp Clin Transplant. 2018 Feb;16(1):116-118. Exp Clin Transplant. 2018. PMID: 29409439 Free article.
OBJECTIVES: Substantial numbers of patients after hematopoietic stem cell transplant need critical care. In Japan, however, data regarding the availability of an intensive care unit and intensivists at hospitals performing hematopoietic stem
OBJECTIVES: Substantial numbers of patients after hematopoietic stem cell transplant need critical care. In Japa …
Long-term complications after hematopoietic cell transplantation.
Majhail NS. Majhail NS. Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):220-227. doi: 10.1016/j.hemonc.2017.05.009. Epub 2017 Jun 13. Hematol Oncol Stem Cell Ther. 2017. PMID: 28641097 Free PMC article. Review.
The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. Among patients whose disease remains in remission for the first 2-5years after transplantation, it is estimated that approximately 80- …
The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT) survivors continues to increase. A …
136,710 results
Jump to page
Feedback